Related Experiment Video
Updated: Feb 26, 2026

Genetic Encoding of a Non-Canonical Amino Acid for the Generation of Antibody-Drug Conjugates Through a Fast Bioorthogonal Reaction
Published on: September 14, 2018
Extensive Survey of Antibody Invariant Positions for Efficient Chemical Conjugation Using Expanded Genetic Codes
Akifumi Kato, Mitsuo Kuratani1,2, Tatsuo Yanagisawa1,2
1RIKEN Structural Biology Laboratory , 1-7-22 Suehiro-cho, Tsurumi-ku, Yokohama 230-0045, Japan.
This study introduces a new method for chemically modifying antibodies using non-natural amino acids, enabling precise site-specific conjugation for advanced antibody therapies. The approach successfully created novel antibody formats with potential therapeutic applications.
Area of Science:
- Biotechnology
- Chemical Biology
- Protein Engineering
Background:
- Site-specific protein conjugation is crucial for advancing antibody-based technologies like antibody drug conjugates and bispecific antibodies.
- Incorporating non-natural amino acids into antibodies offers site specificity and enables bio-orthogonal chemistry.
- Current methods face challenges due to variable efficiency in incorporating non-natural amino acids at different antibody sites.
Purpose of the Study:
- To develop a robust and efficient method for synthesizing chemically functionalized antibodies with non-natural amino acids at defined positions.
- To identify new sites for efficient chemical conjugation in antibody fragments (Fab).
- To engineer a novel antibody format, Variabodies, using the identified conjugation sites.
Main Methods:
- Utilized codon reassignment technology for the synthesis of antibodies incorporating Nε-(o-azidobenzyloxycarbonyl)-l-lysine (o-Az-Z-Lys).
- Employed X-ray crystallography to analyze the structure and accessibility of the incorporated azido group in a Fab variant.
- Engineered Variabodies by chemically connecting two Fab molecules at newly identified sites.
Main Results:
- Successfully synthesized chemically functionalized antibodies with o-Az-Z-Lys at defined positions with high efficiency.
- Identified multiple new sites in Fab-constant domains suitable for efficient chemical conjugation.
- Created Variabodies, a novel antibody format, with some variants demonstrating agonistic activity.
Conclusions:
- The developed approach significantly enhances the availability of antibodies for chemical conjugation.
- This method facilitates the identification of new conjugation sites and the engineering of novel antibody formats.
- The findings may contribute to the development of new therapeutic antibodies with diverse functionalities.
More Related Videos
Related Concept Videos
Antibody Structure
Antibodies, also known as immunoglobulins (Ig), are essential players of the adaptive immune system. These antigen-binding proteins are produced by B cells and make up 20 percent of the total blood plasma by weight. In mammals, antibodies fall into five different classes, which each elicits a different biological response upon antigen binding.
The Y-Shaped Structure of Antibodies Consists of Four Polypeptide Chains
Antibodies consist of four polypeptide chains: two identical heavy...
Diversity of Antigen Receptors
Before encountering any antigen, lymphocytes express these receptors. On B cells, the antigen receptor is a membrane-bound antibody molecule called BCR; on T cells, it is a T cell receptor or TCR. B and T cell receptors are composed of two...
Conjugation
Antibody Structure and Classes
The basic structure of an antibody consists of four protein chains: two identical heavy chains and two identical light chains. These chains are held together by disulfide bonds and other non-covalent interactions, forming a Y-shaped structure.

